Amer Bio Medica
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rap… Read more
Market Cap & Net Worth: Amer Bio Medica (ABMC)
Amer Bio Medica (PINK:ABMC) has a market capitalization of $4.81K ($4.81K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46506 globally and #14485 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amer Bio Medica's stock price $0.00 by its total outstanding shares 48098500 (48.10 Million).
Amer Bio Medica Market Cap History: 2015 to 2025
Amer Bio Medica's market capitalization history from 2015 to 2025. Data shows change from $6.30 Million to $4.81K (-53.14% CAGR).
Amer Bio Medica Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amer Bio Medica's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.53x
Amer Bio Medica's market cap is 0.53 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $6.30 Million | $6.32 Million | -$333.00K | 1.00x | N/A |
| 2016 | $5.05 Million | $5.61 Million | -$345.00K | 0.90x | N/A |
| 2017 | $4.81 Million | $4.91 Million | -$545.00K | 0.98x | N/A |
| 2018 | $3.31 Million | $3.87 Million | -$1.03 Million | 0.85x | N/A |
| 2019 | $3.37 Million | $3.65 Million | -$681.00K | 0.92x | N/A |
| 2020 | $6.25 Million | $4.15 Million | -$796.00K | 1.51x | N/A |
| 2021 | $1.92 Million | $2.22 Million | -$463.00K | 0.87x | N/A |
| 2022 | $480.99K | $913.00K | -$1.41 Million | 0.53x | N/A |
Competitor Companies of ABMC by Market Capitalization
Companies near Amer Bio Medica in the global market cap rankings as of March 19, 2026.
Key companies related to Amer Bio Medica by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Amer Bio Medica Historical Marketcap From 2015 to 2025
Between 2015 and today, Amer Bio Medica's market cap moved from $6.30 Million to $ 4.81K, with a yearly change of -53.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.81K | 0.00% |
| 2024 | $4.81K | -50.00% |
| 2023 | $9.62K | -98.00% |
| 2022 | $480.99K | -75.00% |
| 2021 | $1.92 Million | -69.23% |
| 2020 | $6.25 Million | +85.71% |
| 2019 | $3.37 Million | +1.74% |
| 2018 | $3.31 Million | -31.20% |
| 2017 | $4.81 Million | -4.76% |
| 2016 | $5.05 Million | -19.85% |
| 2015 | $6.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Amer Bio Medica was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.81K USD |
| MoneyControl | $4.81K USD |
| MarketWatch | $4.81K USD |
| marketcap.company | $4.81K USD |
| Reuters | $4.81K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.